The Mississippi Board of Pharmacy commissioned HORNE to conduct an audit of OptumRx commercial prescription drug claims for the calendar year 2022. The audit findings are contested by OptumRx until final resolution of the matter.
The Mississippi Board of Pharmacy commissioned HORNE to conduct an audit of OptumRx commercial prescription drug claims for the calendar year 2022. The audit findings are contested by OptumRx until final resolution of the matter.